Nonvariceal upper gastrointestinal bleeding

Endoscopy

Volumn 34, Issue 2, 2002, Pages 111-118

  Rollhauser, Carlos ^a   Fleischer, D E ^b  

^a HOSPITAL PRIVADO   (Argentina)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; ANTACID AGENT; ANTICOAGULANT AGENT; ANTIVITAMIN K; BISMUTH CITRATE; ENBUCRILATE; ETHIBLOC; GLYCERYL TRINITRATE; HISTAMINE H2 RECEPTOR ANTAGONIST; METRONIDAZOLE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; STEROID; STOMACH SECRETION INHIBITOR; TETRACYCLINE; VASODILATOR AGENT;

ACCURACY; ADJUVANT THERAPY; CLINICAL PROTOCOL; CLINICAL TRIAL; CLIP; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIEULAFOY DISEASE; DOPPLER ECHOGRAPHY; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; DRUG POTENTIATION; ENDOSCOPIC THERAPY; ENDOSCOPY; ENTERIC COATED TABLET; EPIDEMIOLOGICAL DATA; ERADICATION THERAPY; FACTORIAL ANALYSIS; GASTROINTESTINAL HEMORRHAGE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEMOSTASIS; HUMAN; HUMAN EXPERIMENT; INTERVENTIONAL RADIOLOGY; MALLORY WEISS SYNDROME; MEDICAL CARE; MEDICAL RESEARCH; META ANALYSIS; MORBIDITY; MORTALITY; NONHUMAN; OUTCOMES RESEARCH; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; RISK FACTOR; TREATMENT FAILURE; TREATMENT OUTCOME; UPPER GASTROINTESTINAL TRACT;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-ULCER AGENTS; ENDOSCOPY, GASTROINTESTINAL; GASTROINTESTINAL HEMORRHAGE; HEMOSTASIS, SURGICAL; HUMANS; OMEPRAZOLE; PEPTIC ULCER HEMORRHAGE; PROGNOSIS; RISK ASSESSMENT;

EID: 0036162840     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-19853     Document Type: Review

References (50)

1. Epidemiology and course of acute upper gastro-intestinal haemorrhage in four French geographical areas
2. Risk assessment after acute upper gastrointestinal haemorrhage
3. Selection of patients for early discharge or outpatient care after acute upper gastrointestinal haemorrhage. National Audit of Acute Upper Gastrointestinal Haemorrhage
4. Incidence, risk factors, and prognosis of gastrointestinal hemorrhage complicating acute renal failure
5. Smoking and alcohol intake as risk factors for bleeding and perforated peptic ulcers: A population-based cohort study
6. Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient
7. Recent nonsteroidal anti-inflammatory drug use increases the risk of early recurrence of bleeding in patients presenting with bleeding ulcer
8. Risk factors for hospitalized gastrointestinal bleeding among older persons. Cardiovascular Health Study Investigators
9. Epidemiologic assessment of the safety of conventional nonsteroidal anti-inflammatory drugs
10. Prospects for changing the burden of nonsteroidal anti-inflammatory drug toxicity
11. Risk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulations
12. Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin
13. Risk of ulcer bleeding in patients infected with Helicobacter pylori taking non-steroidal anti-inflammatory drugs
14. Helicobacter pylori and NSAID gastropathy: An ambiguous association
15. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen
16. Confidence intervals for the number needed to treat
17. Occurrence and relapse of bleeding from duodenal ulcer: Respective roles of acid secretion and Helicobacter pylori infection
18. The effect of the eradication of Helicobacter pylori infection on hemorrhage because of duodenal ulcer
19. Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding
20. Is non-Helicobacter pylori, non-NSAID peptic ulcer a common cause of upper gastrointestinal bleeding? A prospective study of 977 patients
21. Low sensitivity of invasive tests for the detection of Helicobacter pylori infection in patients with bleeding ulcer
22. Role of Doppler US in acute peptic ulcer hemorrhage: Can it predict failure of endoscopic therapy?
23. Do we need more technology to reduce recurrence of bleeding from ulcers?
24. Acute ulcer bleeding: A prospective randomized trial to compare Doppler and Forrest classifications in endoscopic diagnosis and therapy
25. Acute upper gastrointestinal hemorrhage in west of Scotland: Case ascertainment study
26. A risk score to predict need for treatment for upper-gastrointestinal haemorrhage
27. Physician's specialty and variations in the cost of treating patients with acute upper gastrointestinal bleeding
28. Nonvariceal upper gastrointestinal bleeding: Differences in outcome for patients admitted to internal medicine and gastroenterological services
29. Managing patients with acute, nonvariceal gastrointestinal hemorrhage: Development and effectiveness of a clinical care pathway
30. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers
31. Randomised comparison between adrenaline injection alone and adrenaline injection plus heat probe treatment for actively bleeding ulcers
32. Acid suppression in peptic ulcer haemorrhage: A "meta-analysis"
33. Proton pump inhibitors versus H2-antagonists: A meta-analysis of their efficacy in treating bleeding peptic ulcer
34. Enhanced mucosal fibrinolytic activity in gastroduodenal ulcer haemorrhage and the beneficial effect of acid suppression
35. Prognostic value of fibrinolytic tests for hospital outcome in patients with acute upper gastrointestinal hemorrhage
36. Abnormal von Willebrand factor in bleeding angiodysplasias of the digestive tract
37. Effectiveness of endoscopy in patients admitted to the intensive care unit with upper gastrointestinal hemorrhage
38. Endoclips versus heater probe in preventing early recurrent bleeding from peptic ulcer: A prospective and randomized trial
39. Recurrent ulcer bleeding: Is the hemoclip an answer?
40. Randomized trial of N-butyl-2-cyanoacrylate compared with injection of hypertonic saline-epinephrine in the endoscopic treatment of bleeding peptic ulcers
41. Duodenal ulcer perforation following cyanoacrylate injection
42. Bleeding Dieulafoy's lesions and the choice of endoscopic method: Comparing the hemostatic efficacy of mechanical and injection methods
43. Peptic ulcer bleeding: Comparison of two hemostatic procedures
44. Peptic ulcer bleeding
45. Endoscopic hemostasis for bleeding peptic ulcer using a hemostatic clip or pure ethanol injection
46. Efficacy of endoscopic isotonic saline-epinephrine injection for the management of active Mallory-Weiss tears
47. Endoscopic hemoclipping for upper gastrointestinal bleeding due to Mallory-Weiss syndrome
48. Diagnostic failures in endoscopy for acute upper gastrointestinal haemorrhage
49. Dieulafoy lesions: A review of 6 years of experience at a tertiary referral center
50. Embolization for gastrointestinal hemorrhages